MANCHESTER KEITH S

CIK 00012448284 companiesLONDON, X0

SEC Profile

Transactions

Companies

Filings

CIK

0001244828

Recent Transactions

50 trades

Sale
Roivant Sciences Ltd.$ROIV
Common Shares
2025-12-17$23.02/sh−155,076→ 16,542,651 total
Sale
Roivant Sciences Ltd.$ROIV
Common Shares
2025-12-17$23.17/sh−189,538→ 16,353,113 total
Sale
Roivant Sciences Ltd.$ROIV
Common Shares
2025-12-17$23.05/sh−432,718→ 16,697,727 total
Sale
Roivant Sciences Ltd.$ROIV
Common Shares
2025-12-16$23.08/sh−642,282→ 17,130,445 total
Sale
Roivant Sciences Ltd.$ROIV
Common Shares
2025-12-16$22.93/sh−275,000→ 17,772,727 total
Sale
Roivant Sciences Ltd.$ROIV
Common Shares
2025-11-19$20.16/sh−125,000→ 18,222,727 total
Sale
Roivant Sciences Ltd.$ROIV
Common Shares
2025-11-19$20.20/sh−150,000→ 18,347,727 total
Sale
Roivant Sciences Ltd.$ROIV
Common Shares
2025-11-19$20.25/sh−850,000→ 18,497,727 total
Sale
Roivant Sciences Ltd.$ROIV
Common Shares
2025-11-19$20.24/sh−175,000→ 18,047,727 total
Award
Roivant Sciences Ltd.$ROIV
Stock Option (Right to Buy)
2025-09-10+33,726→ 33,726 total
Award
Roivant Sciences Ltd.$ROIV
Common Shares
2025-09-10+14,524→ 1,948,403 total
Other
Roivant Sciences Ltd.$ROIV
Common Shares
2025-06-25−1,170,646→ 1,592,480 total
Other
Roivant Sciences Ltd.$ROIV
Common Shares
2025-06-25−6,837,266→ 0 total
Other
Roivant Sciences Ltd.$ROIV
Common Shares
2025-06-25−6,205,368→ 8,441,428 total
Other
Roivant Sciences Ltd.$ROIV
Common Shares
2025-06-25−3,176,245→ 19,347,727 total
Sale
Roivant Sciences Ltd.$ROIV
Common Shares
2024-09-25$11.77/sh−134,948→ 1,277,178 total
Sale
Roivant Sciences Ltd.$ROIV
Common Shares
2024-09-24$11.63/sh−368,052→ 1,412,126 total
Award
Roivant Sciences Ltd.$ROIV
Stock Option (Right to Buy)
2024-09-10+27,894→ 27,894 total
Award
Roivant Sciences Ltd.$ROIV
Common Shares
2024-09-10+16,406→ 1,780,178 total
Sale
Arbutus Biopharma Corp$ABUS
Common Shares
2024-08-14$3.69/sh−8,846→ 46,069 total
Exercise/Conversion
Arbutus Biopharma Corp$ABUS
Stock Option (Right to Buy)
2024-08-14−54,915→ 0 total
Exercise/Conversion
Arbutus Biopharma Corp$ABUS
Common Shares
2024-08-14$0.56/sh+54,915→ 54,915 total
Award
Arbutus Biopharma Corp$ABUS
Stock Option (Right to Buy)
2024-05-23+67,000→ 67,000 total
Other
Roivant Sciences Ltd.$ROIV
Common Shares
2024-03-07−11,325,233→ 23,105,358 total
Other
Roivant Sciences Ltd.$ROIV
Common Shares
2024-03-07−2,260,661→ 2,763,126 total
Other
Roivant Sciences Ltd.$ROIV
Common Shares
2024-03-07−5,594,064→ 6,837,266 total
Other
Roivant Sciences Ltd.$ROIV
Common Shares
2024-03-07−11,077,765→ 14,646,796 total
Sale
Roivant Sciences Ltd.$ROIV
Common Shares
2023-09-28$11.55/sh−446,394→ 5,023,787 total
Sale
Roivant Sciences Ltd.$ROIV
Common Shares
2023-09-28$11.55/sh−1,104,599→ 12,431,330 total
Sale
Roivant Sciences Ltd.$ROIV
Common Shares
2023-09-28$11.55/sh−3,059,368→ 34,430,591 total
Sale
Roivant Sciences Ltd.$ROIV
Common Shares
2023-09-28$11.55/sh−2,285,783→ 25,724,561 total
Award
Roivant Sciences Ltd.$ROIV
Stock Option (Right to Buy)
2023-09-12+26,595→ 26,595 total
Award
Roivant Sciences Ltd.$ROIV
Common Shares
2023-09-12+17,825→ 69,967 total
Award
Arbutus Biopharma Corp$ABUS
Stock Option (Right to Buy)
2023-05-24+55,000→ 55,000 total
Sale
Roivant Sciences Ltd.$ROIV
Common Shares
2022-11-10$4.75/sh−372,427→ 13,535,929 total
Sale
Roivant Sciences Ltd.$ROIV
Common Shares
2022-11-10$4.75/sh−2,311,643→ 28,010,344 total
Sale
Roivant Sciences Ltd.$ROIV
Common Shares
2022-11-10$4.75/sh−146,079→ 5,470,181 total
Sale
Roivant Sciences Ltd.$ROIV
Common Shares
2022-11-10$4.75/sh−1,092,355→ 37,489,959 total
Other
Roivant Sciences Ltd.$ROIV
Common Shares
2022-11-09−1,196,200→ 38,582,314 total
Award
Roivant Sciences Ltd.$ROIV
Common Shares
2022-09-15+52,142→ 52,142 total
Award
Roivant Sciences Ltd.$ROIV
Stock Option (Right to Buy)
2022-09-15+71,850→ 71,850 total
Award
Arbutus Biopharma Corp$ABUS
Stock Option (Right to Buy)
2022-05-25+41,000→ 41,000 total
Award
Arbutus Biopharma Corp$ABUS
Stock Options
2021-06-03+22,000→ 22,000 total
Award
Arbutus Biopharma Corp$ABUS
Stock Options
2020-05-28+22,000→ 22,000 total
Award
Arbutus Biopharma Corp$ABUS
Stock Options
2019-08-17+22,000→ 22,000 total
Award
Arbutus Biopharma Corp$ABUS
Director Stock Option (Right to Buy)
2018-06-19+22,000→ 22,000 total
Award
Arbutus Biopharma Corp$ABUS
Stock Option (right to buy)
2017-06-21+22,000→ 22,000 total
Award
Arbutus Biopharma Corp$ABUS
Stock Option (right to buy)
2016-06-03+7,500→ 7,500 total
Award
Arbutus Biopharma Corp$ABUS
Stock Option (right to buy)
2015-08-12+7,500→ 7,500 total
Exercise of In-Money
CytoCore, Inc.
Employee Stock Option
2004-02-09$10.15/sh−6,028→ 5,972 total

Companies

Recent Filings

Address

C/O ROIVANT SCIENCES LTD. 7TH FLOOR, 50 BROADWAY

LONDON, X0, SW1H 0DB

View on SEC.gov